The Rafael del Pino Foundation has organised, in collaboration with Technology Review, the Meeting "Successful Bioentrepreneurs. The keys to entrepreneurship and investment in biomedicine in Spain", which will be held on 19 June 2012.
Biomedicine is currently one of the sectors with the greatest development and innovation. The latest advances and cutting-edge research in regenerative medicine, cell therapy, genomics and personalised therapies, among others, make it a field of the future with the possibility of generating successful businesses. During the conference, four young Spanish companies with emerging technologies with high potential in the field of biomedicine will show their advances in this field and the keys to their growth:
- Andrés BallesterosManaging Director of Vivia Biotech
- Begoña CastroFounding Partner and Chief Scientific Officer of Histocell
- Javier EchevarríaChief Executive Officer of Labec Pharma
- Damià TormoManaging Director of BiOncoTech
The event was attended by the director of the Rafael del Pino Foundation, Amadeo PetitbòThe editor of the Spanish-language Technology Review magazine, Pedro Moneo and the president of Suanfarma Biotech, Hector Ara.